{"name": "Ignyta",
 "permalink": "ignyta",
 "crunchbase_url": "http://www.crunchbase.com/company/ignyta",
 "homepage_url": "http://www.ignyta.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "Ignyta",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2011,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@ignyta.com",
 "phone_number": "",
 "description": "",
 "created_at": "Thu Jan 03 11:15:49 UTC 2013",
 "updated_at": "Tue May 21 05:23:50 UTC 2013",
 "overview": "\u003Cp\u003EIgnyta is a scientifically driven biotechnology company catalyzing personalized medicine in autoimmune diseases. Their goals are to revolutionize the quality of biomarkers and tests available to rheumatologists and patients to help them make better informed, more individualized treatment decisions; and to identify truly novel autoimmune disease targets for biopharmaceutical companies to enable the development of precise therapies for patients worldwide. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       50],
      "assets/images/resized/0022/7835/227835v1-max-150x150.jpg"],
     [[210,
       70],
      "assets/images/resized/0022/7835/227835v1-max-250x250.jpg"],
     [[210,
       70],
      "assets/images/resized/0022/7835/227835v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$6.5M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://www.prweb.com/releases/2012/12/prweb10280690.htm",
    "source_description": "Ignyta Ends 2012 with Oversubscribed, Expanded Series B Financing",
    "raised_amount": 5500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 12,
    "funded_day": 31,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "City Hill Ventures",
         "permalink": "city-hill-ventures",
         "image":
          {"available_sizes":
            [[[150,
               35],
              "assets/images/resized/0023/2448/232448v2-max-150x150.png"],
             [[250,
               58],
              "assets/images/resized/0023/2448/232448v2-max-250x250.png"],
             [[366,
               86],
              "assets/images/resized/0023/2448/232448v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Colt Ventures",
         "permalink": "colt-ventures",
         "image":
          {"available_sizes":
            [[[150,
               48],
              "assets/images/resized/0026/2908/262908v1-max-150x150.jpg"],
             [[213,
               69],
              "assets/images/resized/0026/2908/262908v1-max-250x250.jpg"],
             [[213,
               69],
              "assets/images/resized/0026/2908/262908v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "debt_round",
    "source_url": "http://pevc.dowjones.com/article?an=DJFVW00020130228e92spudj4\u0026from=alert\u0026pid=32\u0026ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020130228e92spudj4%26from%3dalert%26pid%3d32",
    "source_description": "Ignyta Receives $1M Capital Term Loan From Silicon Valley Bank",
    "raised_amount": 1000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 2,
    "funded_day": 28,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": null,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "http://www.bloomberg.com/article/2013-05-20/aEC5OoPhU3Jw.html",
    "source_description": "Ignyta Announces Acquisition of Actagene Oncology and Entry into Oncology Personalized Medicine",
    "acquired_year": 2013,
    "acquired_month": 5,
    "acquired_day": 20,
    "company":
     {"name": "Actagene Oncology",
      "permalink": "actagene-oncology",
      "image": null}}],
 "offices":
  [{"description": "",
    "address1": "11575 Sorrento Valley Road",
    "address2": "Suite 200 ",
    "zip_code": "92121",
    "city": "San Diego",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": 32.913192,
    "longitude": -117.231074}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        98],
       "assets/images/resized/0022/7836/227836v1-max-150x150.jpg"],
      [[250,
        164],
       "assets/images/resized/0022/7836/227836v1-max-250x250.jpg"],
      [[450,
        296],
       "assets/images/resized/0022/7836/227836v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}